|
|
Gene Symbol |
TOX3 |
|
Aliases |
CAGF9, TNRC9 |
|
Entrez Gene ID |
|
|
Gene Name |
TOX high mobility group box family member 3 |
|
Chromosomal Location |
16q12.1 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene contains an HMG-box, indicating that it may be involved in bending and unwinding of DNA and alteration of chromatin structure. The C-terminus of the encoded protein is glutamine-rich due to CAG repeats in the coding sequence. A minor allele of this gene has been implicated in an elevated risk of breast cancer. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2009]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
SNPs
SNP Id |
Upstream Sequence |
SNP |
Downstream Sequence |
Functional Significance |
References |
rs4784165 |
GGACTGCAGGGCGCTCACGCTTGCTG |
C/T |
GAAGTAAGGCGTTTGAAGGTGAGGC |
|
25311971, 28537684, 22885925 | |
|
Protein Information |
|
Protein Name |
TOX high mobility group box family member 3, CAG trinucleotide repeat-containing gene F9 protein, trinucleotide repeat-containing gene 9 protein |
|
Function |
Transcriptional coactivator of the p300/CBP-mediated transcription complex. Activates transactivation through cAMP response element (CRE) sites. Protects against cell death by inducing antiapoptotic and repressing pro-apoptotic transcripts. Stimulates transcription from the estrogen-responsive or BCL-2 promoters. Required for depolarization-induced transcription activation of the C-FOS promoter in neurons. Associates with chromatin to the estrogen-responsive C3 promoter region. |
|
|
|
|
|
UniProt |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00505 |
HMG_box |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000223862 |
|
P04808 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Breast Cancer |
|
Liver Cancer |
|
Breast Cancer,Male |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
LHCGR, THADA, FSHR, KHDRBS3, YAP1 and RAB5B |
hyperandrogenemia, menstruation number/year and polycystic ovary morphology |
rs11075466 |
|
Direct
|
862 women with PCOS and 860 controls in the Korean population |
The GRS was higher in women with PCOS than in controls (8.8 versus 8.2, P < 0.01) and was significantly associated with PCOS after adjusting for age and BMI |
|
|
|
|